Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 796 AL 810

Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam)

Feldman HH, Luchsinger JA, Léger GC, Taylor C, Jacobs DM, Salmon DP, Edland SD, Messer K, Revta C, Flowers SA, Jones KS, Koulman A, Yarasheski KE, Verghese PB, Venkatesh V, Zetterberg H, Durant J, Lupo JL, Gibson GE; ADCS BenfoTeam Study Group.

PLoS One. 2024 May 29;19(5):e0302998. doi: 10.1371/journal.pone.0302998. eCollection 2024.

Photobiomodulation Therapy: A Novel Therapeutic Approach to Alzheimer's Disease Made Possible by the Evidence of a Brain-Gut Interconnection

Blivet G, Roman FJ, Lelouvier B, Ribière C, Touchon J.

J Integr Neurosci. 2024 Apr 30;23(5):92. doi: 10.31083/j.jin2305092.

The Role of Microglia with Mitochondrial Dysfunction and Its Therapeutic Prospects in Alzheimer's Disease

Li Y, Li T, Chen T, Li C, Yu W, Xu Y, Zeng X, Zheng F.

J Integr Neurosci. 2024 Apr 30;23(5):91. doi: 10.31083/j.jin2305091.

Review of valiltramiprosate (ALZ-801) for the treatment of Alzheimer's disease: a novel small molecule with disease modifying potential

Lee D, Antonsdottir IM, Clark ED, Porsteinsson AP.

Expert Opin Pharmacother. 2024 May;25(7):791-799. doi: 10.1080/14656566.2024.2360069. Epub 2024 May 30.

Role of PIM Kinase Inhibitor in the Treatment of Alzheimer's Disease

Meur S, Mukherjee S, Roy S, Karati D.

Mol Neurobiol. 2024 Dec;61(12):10941-10955. doi: 10.1007/s12035-024-04257-7. Epub 2024 May 30.

Alzheimer Disease-Link With Major Depressive Disorder and Efficacy of Antidepressants in Modifying its Trajectory

Fakih N, Fakhoury M.

J Psychiatr Pract. 2024 May 1;30(3):181-191. doi: 10.1097/PRA.0000000000000779.

Diabetes mellitus and Alzheimer's disease: Understanding disease mechanisms, their correlation, and promising dual activity of selected herbs

Pramanik R, Dey A, Chakrabarty AK, Banerjee D, Narwaria A, Sharma S, Rai RK, Katiyar CK, Dubey SK.

J Ethnopharmacol. 2024 Oct 28;333:118402. doi: 10.1016/j.jep.2024.118402. Epub 2024 May 29.

Targeting Biometals in Alzheimer's Disease with Metal Chelating Agents Including Coumarin Derivatives

Gucký A, Hamuľaková S.

CNS Drugs. 2024 Jul;38(7):507-532. doi: 10.1007/s40263-024-01093-0. Epub 2024 Jun 3.

Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agents

Pereira M, Cruz MT, Fortuna A, Bicker J.

Drug Discov Today. 2024 Jul;29(7):104052. doi: 10.1016/j.drudis.2024.104052. Epub 2024 Jun 1.

Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit

Høilund-Carlsen PF, Alavi A, Barrio JR, Castellani RJ, Costa T, Herrup K, Kepp KP, Neve RL, Perry G, Revheim ME, Robakis NK, Sensi SL, Vissel B.

Ageing Res Rev. 2024 Aug;99:102348. doi: 10.1016/j.arr.2024.102348. Epub 2024 Jun 1.

Unlocking hope: GSK-3 inhibitors and Wnt pathway activation in Alzheimer's therapy

Sai Varshini M, Aishwarya Reddy R, Thaggikuppe Krishnamurthy P.

J Drug Target. 2024 Sep;32(8):909-917. doi: 10.1080/1061186X.2024.2365263. Epub 2024 Jun 11.

Alzheimer's disease and drug delivery across the blood-brain barrier: approaches and challenges

Iqbal I, Saqib F, Mubarak Z, Latif MF, Wahid M, Nasir B, Shahzad H, Sharifi-Rad J, Mubarak MS.

Eur J Med Res. 2024 Jun 8;29(1):313. doi: 10.1186/s40001-024-01915-3.

Multi-target drugs for Alzheimer's disease

Turgutalp B, Kizil C.

Trends Pharmacol Sci. 2024 Jul;45(7):628-638. doi: 10.1016/j.tips.2024.05.005. Epub 2024 Jun 9.

Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial)

Zeng L, Perin J, Gross AL, Shade D, Lanctôt KL, Lerner AJ, Mintzer JE, Brawman-Mintzer O, Padala PR, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Herrmann N, Rosenberg PB.

Int J Geriatr Psychiatry. 2024 Jun;39(6):e6108. doi: 10.1002/gps.6108.

Signaling pathways in the treatment of Alzheimer's disease with acupuncture: a narrative review

Ke C, Shan S, Tan Y, Cao Y, Xie Z, Shi S, Pan J, Zhang W.

Acupunct Med. 2024 Aug;42(4):216-230. doi: 10.1177/09645284241256669. Epub 2024 Jun 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias